FRA:3XV (Sweden)  
Xvivo Perfusion AB logo

Xvivo Perfusion AB

€ 19.30 (-3.5%) Aug 18
P/E:
249.15
P/B:
4.38
Market Cap:
€ 566.95M ($ 571.50M)
Enterprise V:
€ 537.53M ($ 541.84M)
Volume:
-
Avg Vol (2M):
100.00
Also Trade In:
Volume:
-
Market Cap €:
566.95M
Market Cap $:
571.50M
PE Ratio:
249.15
Avg Vol (2-Month):
100.00
Enterprise Value €:
537.53M
Enterprise Value $:
541.84M
PB Ratio:
4.38
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download

Business Description

Xvivo Perfusion AB
Massans gata 10, P.O. Box 53015, Gothenburg, SWE, SE-400 14
Description
Xvivo Perfusion AB is a medical technology company dedicated to extending the life of all major organs so transplant teams around the world can save more lives. Its solutions allow clinicians and researchers to push the boundaries of transplantation medicine. It operates in three segments namely, Durable goods, sales and rental revenues from machines used in organ perfusion; All operations except durable goods, revenue streams from sales of consumables and services used in preservation and perfusion of organs; Services, revenue from sales of services in organ recovery.
Name Current Vs Industry Vs History
Cash-To-Debt 49.48
Equity-to-Asset 0.85
Debt-to-Equity 0.01
Debt-to-EBITDA 0.29
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 17.11
Distress
Grey
Safe
Beneish M-Score -1.34
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 21.47
9-Day RSI 32.6
14-Day RSI 38.32
6-1 Month Momentum % -14.85
12-1 Month Momentum % -50.61

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 6.48
Quick Ratio 5.51
Cash Ratio 4.11
Days Inventory 290.82
Days Sales Outstanding 77.51
Days Payable 83.31

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -3.8

Financials (Next Earnings Date:2022-10-27)

FRA:3XV's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 31.446
EPS (TTM) (€) 0.077
Beta 0
Volatility % 50
14-Day RSI 38.32
14-Day ATR (€) 0.457517
20-Day SMA (€) 20.89
12-1 Month Momentum % -50.61
52-Week Range (€) 18.48 - 44.35
Shares Outstanding (Mil) 29.56

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Xvivo Perfusion AB Filings

Document Form Filing Date
No Filing Data